• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 159-173 of 250 results

1116 Exhibit: Declaration of Harry ¿¿¿Warren¿¿¿ Johnson, dated August 24, 2020

Document PGR2020-00086, No. 1116 Exhibit - Declaration of Harry ¿¿¿Warren¿¿¿ Johnson, dated August 24, 2020 (P.T.A.B. Sep. 21, 2020)

cite Cite Document

1006 Exhibit: Hern¿¿ndez S¿¿nchez et al, Aluminum in Parenteral Nutrition A System...

Document PGR2020-00086, No. 1006 Exhibit - Hern¿¿ndez S¿¿nchez et al, Aluminum in Parenteral Nutrition A Systematic Review, (P.T.A.B. Sep. 21, 2020)

cite Cite Document

1122 Exhibit: July 23, 2020 Office Action in Application No 16773,641

Document PGR2020-00086, No. 1122 Exhibit - July 23, 2020 Office Action in Application No 16773,641 (P.T.A.B. Sep. 21, 2020)

cite Cite Document

1045 Exhibit: UCSF CHILDREN¿¿¿S HOSPITAL INTENSIVE CARE NURSERY HOUS...

Document PGR2020-00086, No. 1045 Exhibit - UCSF CHILDREN¿¿¿S HOSPITAL INTENSIVE CARE NURSERY HOUSE STAFF MANUAL 2004 2006 (P.T.A.B. Sep. 21, 2020)

cite Cite Document

2001 Exhibit: Declaration of Dr Robert J Kuhn

Document PGR2020-00086, No. 2001 Exhibit - Declaration of Dr Robert J Kuhn (P.T.A.B. Jan. 27, 2021)

cite Cite Document

1076 Exhibit: USP 32NF 18, The US Pharmacopeial Convention 1995

Document PGR2020-00086, No. 1076 Exhibit - USP 32NF 18, The US Pharmacopeial Convention 1995 (P.T.A.B. Sep. 21, 2020)

cite Cite Document

1015 Exhibit: Koo, Aluminum in Parenteral Nutrition Solution¿¿¿ Sources and Possib...

Document PGR2020-00086, No. 1015 Exhibit - Koo, Aluminum in Parenteral Nutrition Solution¿¿¿ Sources and Possible Alternatives (P.T.A.B. Sep. 21, 2020)

cite Cite Document

1042 Exhibit: Prescribing Information for Selenious Acid Injection revised 042019

Document PGR2020-00086, No. 1042 Exhibit - Prescribing Information for Selenious Acid Injection revised 042019 (P.T.A.B. Sep. 21, 2020)

cite Cite Document

1031 Exhibit: Patel et al, Stability Considerations for Biopharmaceuticals, Part 1 Ov...

Document PGR2020-00086, No. 1031 Exhibit - Patel et al, Stability Considerations for Biopharmaceuticals, Part 1 Overview of Protein and Peptide Degradation Pathways (P.T.A.B. Sep. 21, 2020)

cite Cite Document

1028 Exhibit: Maget, Use of an Oxygen Extractor to Minimize Oxidation of Compou...

Document PGR2020-00086, No. 1028 Exhibit - Maget, Use of an Oxygen Extractor to Minimize Oxidation of Compounded Preparations (P.T.A.B. Sep. 21, 2020)

cite Cite Document

1053 Exhibit: August 2017 Important Drug Warning Letter from Patent Owner to He...

Document PGR2020-00086, No. 1053 Exhibit - August 2017 Important Drug Warning Letter from Patent Owner to Health Care Provider (P.T.A.B. Sep. 21, 2020)

cite Cite Document

1037 Exhibit: Yu et al, Understanding Pharmaceutical Quality by Design

Document PGR2020-00086, No. 1037 Exhibit - Yu et al, Understanding Pharmaceutical Quality by Design (P.T.A.B. Sep. 21, 2020)

cite Cite Document

2011 Exhibit: Jay M Mirtallo, Aluminum Contamination of Parenteral Nutrition Fluids

Document PGR2020-00086, No. 2011 Exhibit - Jay M Mirtallo, Aluminum Contamination of Parenteral Nutrition Fluids (P.T.A.B. Jan. 27, 2021)

cite Cite Document

1024 Exhibit: Asquith et al, The Photochemical Degradation of Cystine in Aqueous ...

Document PGR2020-00086, No. 1024 Exhibit - Asquith et al, The Photochemical Degradation of Cystine in Aqueous Solution in the Presence of Air, (P.T.A.B. Sep. 21, 2020)

cite Cite Document

1018 Exhibit: FDA GUIDANCE FOR INDUSTRY Q8R2 PHARMACEUTICAL DEVELO...

Document PGR2020-00086, No. 1018 Exhibit - FDA GUIDANCE FOR INDUSTRY Q8R2 PHARMACEUTICAL DEVELOPMENT Nov 2009 (P.T.A.B. Sep. 21, 2020)

cite Cite Document
<< 1 2 3 4 5 ... 11 12 13 14 15 16 17 18 >>